Related Experiment Video
Updated: Oct 16, 2025
08:55
Fabrication and Characterization of Layer-By-Layer Janus Base Nano-Matrix to Promote Cartilage Regeneration
Published on: July 6, 2022
2.2K
Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Reecha Madaan1, Rajeev K Singla2,3, Suresh Kumar4
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Current Topics in Medicinal Chemistry
|October 15, 2021
Summary
Bergenin, a plant compound, shows promise for treating liver, inflammation, cancer, and infections. Nanotechnology may improve its effectiveness as a potential therapeutic agent.
Area of Science:
- Pharmacology
- Natural Products
- Nanotechnology
Background:
- Bergenin (4-O-methyl gallic acid glucoside) is a bioactive compound found in various plant families.
- Existing literature on bergenin's pharmacology, structure-activity relationship, and nanotechnological applications is fragmented.
Purpose of the Study:
- To compile and review scattered information on bergenin.
- To highlight its diverse pharmacological activities and potential therapeutic applications.
- To explore the role of nanotechnology in enhancing bergenin's bioavailability.
Main Methods:
- Comprehensive literature search across electronic databases (Sci Finder, PubMed, Google Scholar).
- Analysis of reported pharmacological activities, structure-activity relationships, and molecular docking studies.
- Review of nanotechnological strategies for drug delivery.
Main Results:
- Bergenin exhibits significant hepatoprotective, anti-inflammatory, anticancer, neuroprotective, antiviral, and antimicrobial activities.
- Molecular docking indicates the isocoumarin pharmacophore is crucial for its bioactivities.
- Nanotechnology offers a viable approach to overcome bergenin's poor bioavailability.
Conclusions:
- Bergenin possesses broad therapeutic potential and can serve as a lead molecule for developing novel drugs.
- Semisynthetic derivatives of bergenin may offer improved efficacy and safety.
- Bergenin is a promising candidate for clinical application in modern therapeutics.
